Sign in

CIK 0001401667 · Accelerated filer<br>Smaller reporting company

PUMA BIOTECHNOLOGY, INC.

Sign in to watch
Ticker
PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770683487
Phone
(424) 248-6500
Business address
10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
Former names
INNOVATIVE ACQUISITIONS CORP
  1. 4 Planned sale Chief Financial Officer sold 10,227 shares at $3.15 ($32,232)
  2. 4 Planned sale Chief Commercial Officer sold 9,437 shares at $3.15 ($29,743)
  3. 4 Planned sale See Remarks sold 8,633 shares at $3.15 ($27,209)
  4. 4 Planned sale President and CEO sold 33,841 shares at $3.15 ($106,657)
  5. 4 Open-market sale Director sold 23,358 shares at $3.49 ($81,466)
  6. 4 Planned sale Chief Financial Officer sold 4,156 shares at $3.70 ($15,382)
  7. 4 Planned sale Chief Commercial Officer sold 2,598 shares at $3.70 ($9,615)
  8. 4 Planned sale See Remarks sold 3,637 shares at $3.70 ($13,461)
  9. 4 Planned sale President and CEO sold 21,920 shares at $3.70 ($81,128)
  10. 4 Planned sale Chief Financial Officer sold 5,295 shares at $3.27 ($17,307)
  11. 4 Planned sale Chief Commercial Officer sold 6,051 shares at $3.27 ($19,778)
  12. 4 Planned sale See Remarks sold 4,349 shares at $3.27 ($14,215)
  13. 4 Planned sale President and CEO sold 18,885 shares at $3.27 ($61,726)
  14. 4 Grant or award Director acquired 27,000 shares (grant or award)
  15. 4 Grant or award Director acquired 27,000 shares (grant or award)
  16. 4 Grant or award Director acquired 27,000 shares (grant or award)
  17. 4 Grant or award Director acquired 27,000 shares (grant or award)
  18. 4 Grant or award Director acquired 27,000 shares (grant or award)
  19. 4 Grant or award Director acquired 27,000 shares (grant or award)
  20. 4 Grant or award Director acquired 27,000 shares (grant or award)

Page 3 of 24 · 471 filings